Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,186 | $1,165 | $1,409 | $1,044 |
| - Cash | $125 | $231 | $85 | $284 |
| + Debt | $3 | $0 | $1 | $0 |
| Enterprise Value | $1,064 | $934 | $1,324 | $760 |
| Revenue | $131 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $126 | -$0 | -$1 | -$0 |
| % Margin | 96% | – | – | – |
| EBITDA | -$86 | -$189 | -$142 | -$73 |
| % Margin | -65.8% | – | – | – |
| Net Income | -$95 | -$189 | -$142 | -$71 |
| % Margin | -72.8% | – | – | – |
| EPS Diluted | -1.02 | -2.37 | -2.02 | -1.14 |
| % Growth | 57% | -17.3% | -77.2% | – |
| Operating Cash Flow | -$78 | -$147 | -$110 | -$49 |
| Capital Expenditures | -$2 | -$3 | -$0 | -$8 |
| Free Cash Flow | -$80 | -$150 | -$110 | -$57 |